172 related articles for article (PubMed ID: 32719243)
1. Relevance of serum and salivary sialic acid in oral cancer diagnostics.
Guruaribam VD; Sarumathi T
J Cancer Res Ther; 2020; 16(3):401-404. PubMed ID: 32719243
[TBL] [Abstract][Full Text] [Related]
2. A non-invasive study to estimate and compare salivary sialic acid level as tumor marker in patients with pre-cancer and oral cancer.
Jacob TV; Ramesh M; Murali S; Ramesh K; Sanjay PR; Abraham P
J Cancer Res Ther; 2016; 12(2):634-9. PubMed ID: 27461623
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of salivary sialic acid as a tumor marker in tobacco chewers with oral cancer.
Azeem MS; Yesupatham ST; Mohiyuddin SMA; Sumanth V; Ravishankar S
J Cancer Res Ther; 2020; 16(3):605-611. PubMed ID: 32719275
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of salivary sialic acid, total protein, and total sugar in oral cancer: a preliminary report.
Sanjay PR; Hallikeri K; Shivashankara AR
Indian J Dent Res; 2008; 19(4):288-91. PubMed ID: 19075429
[TBL] [Abstract][Full Text] [Related]
5. Sialic acid as a biomarker of oral potentially malignant disorders and oral cancer.
Achalli S; Madi M; Babu SG; Shetty SR; Kumari S; Bhat S
Indian J Dent Res; 2017; 28(4):395-399. PubMed ID: 28836530
[TBL] [Abstract][Full Text] [Related]
6. Salivary biomarkers for oral cancer and pre-cancer screening: a review.
Kaur J; Jacobs R; Huang Y; Salvo N; Politis C
Clin Oral Investig; 2018 Mar; 22(2):633-640. PubMed ID: 29344805
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of serum and salivary total sialic acid and α-l-fucosidase in patients with oral precancerous conditions and oral cancer.
Vajaria BN; Patel KR; Begum R; Shah FD; Patel JB; Shukla SN; Patel PS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Jun; 115(6):764-71. PubMed ID: 23570662
[TBL] [Abstract][Full Text] [Related]
8. Role of Salivary Biomarkers in Oral Cancer Detection.
Khurshid Z; Zafar MS; Khan RS; Najeeb S; Slowey PD; Rehman IU
Adv Clin Chem; 2018; 86():23-70. PubMed ID: 30144841
[TBL] [Abstract][Full Text] [Related]
9. Altered serum and salivary C-reactive protein levels in patients with oral premalignant lesions and oral squamous cell carcinoma.
Metgud R; Bajaj S
Biotech Histochem; 2016; 91(2):96-101. PubMed ID: 26529498
[TBL] [Abstract][Full Text] [Related]
10. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
11. Salivary glyco-sialylation changes monitors oral carcinogenesis.
Vajaria BN; Patel KR; Begum R; Patel JB; Shah FD; Joshi GM; Patel PS
Glycoconj J; 2014 Dec; 31(9):649-59. PubMed ID: 25318700
[TBL] [Abstract][Full Text] [Related]
12. Inflammation in the assessment of salivary cytokines in oral squamous cell carcinoma diagnosis.
Özçaka Ö; Epstein JB; Güneri P
Oral Oncol; 2017 Aug; 71():96-98. PubMed ID: 28688699
[No Abstract] [Full Text] [Related]
13. Comparison of Salivary and Serum Alkaline Phosphates Level and Lactate Dehydrogenase Levels in Patients with Tobacco Related Oral Lesions with Healthy Subjects - A Step Towards Early Diagnosis.
Goyal G
Asian Pac J Cancer Prev; 2020 Apr; 21(4):983-991. PubMed ID: 32334459
[TBL] [Abstract][Full Text] [Related]
14. Salivary Her2/neu Levels in Differentiation of Oral Premalignant Disorders and Oral Squamous Cell Carcinomas.
Varun C; Dineshkumar T; Jayant VS; Rameshkumar A; Rajkumar K; Rajashree P; Mathew J; Arunvignesh RK
Asian Pac J Cancer Prev; 2015; 16(14):5773-7. PubMed ID: 26320450
[TBL] [Abstract][Full Text] [Related]
15. High-throughput screening of saliva for early detection of oral cancer: a pilot study.
Szanto I; Mark L; Bona A; Maasz G; Sandor B; Gelencser G; Turi Z; Gallyas F
Technol Cancer Res Treat; 2012 Apr; 11(2):181-8. PubMed ID: 22335413
[TBL] [Abstract][Full Text] [Related]
16. Biochemical analysis of cytokeratin fragment 21-1 concentration and expression of cytokeratin 19 in oral potentially malignant disorders.
Rathore AS; Katyal S; Jain A; Shetty DC
J Cancer Res Ther; 2020; 16(3):452-457. PubMed ID: 32719250
[TBL] [Abstract][Full Text] [Related]
17. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
[TBL] [Abstract][Full Text] [Related]
18. Serum and salivary levels of albumin as diagnostic tools for oral pre-malignancy and oral malignancy.
Metgud R; Patel S
Biotech Histochem; 2014 Jan; 89(1):8-13. PubMed ID: 23738795
[TBL] [Abstract][Full Text] [Related]
19. Salivary total sialic acid levels increase in breast cancer patients: a preliminary study.
Oztürk LK; Emekli-Alturfan E; Kaşikci E; Demir G; Yarat A
Med Chem; 2011 Sep; 7(5):443-7. PubMed ID: 21801151
[TBL] [Abstract][Full Text] [Related]
20. Salivary L-fucose as a biomarker for oral potentially malignant disorders and oral cancer.
Sharma M; Sharma E; Prabhu V; Pai VR; D'souza JM; Harish S; Jose M
J Cancer Res Ther; 2020; 16(3):546-550. PubMed ID: 32719265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
